Refine
Has Fulltext
- yes (59)
Is part of the Bibliography
- yes (59)
Year of publication
Document Type
- Journal article (59)
Language
- English (59)
Keywords
- colorectal cancer (7)
- inflammatory bowel disease (3)
- CRC (2)
- Crohn's disease (2)
- Germany (2)
- Rectal cancer (2)
- antimicrobial stewardship (2)
- chemotherapy (2)
- complication (2)
- endoluminal (2)
- gastric cancer (2)
- gut barrier (2)
- ileocecal resection (2)
- inflammation (2)
- intestinal epithelial barrier (2)
- meta-analysis (2)
- metastasis (2)
- microbial spectrum (2)
- mortality (2)
- negative pressure (2)
- peritoneal carcinomatosis (2)
- surgery (2)
- surgical therapy (2)
- vacuum-assisted closure (2)
- 5-fluorouracil (1)
- Adrenocortical Carcinoma (1)
- BM (1)
- CA19-9 (1)
- COVID-19 (1)
- COVID-19 pandemic (1)
- CX5461 (1)
- Caco2 cells (1)
- Carcinomatosis (1)
- Chirurgie (1)
- Claudin2 (1)
- Crohn’s Disease (1)
- Crohn’s disease (1)
- Cushing (1)
- Dsg2 (1)
- EDS (1)
- Ehlers-Danlos syndrome (1)
- Epstein-Barr virus (1)
- FWGE (1)
- GDNF5 (1)
- GIST (1)
- Improved survival (1)
- KIT (1)
- Kono-S anastomosis (1)
- Krebs <Medizin> (1)
- LAMN (1)
- LND (1)
- LNE (1)
- Laparoscopy (1)
- Lymph nodes (1)
- MAPK pathway (1)
- MAPK signaling cascades (1)
- MIZ1 (1)
- MTL30 (1)
- MYC (1)
- Medizin (1)
- Minimally invasive surgery (1)
- Oncology (1)
- Organoids (1)
- PCI (1)
- PCR (1)
- PDGF (1)
- PI-3-kinase (1)
- PI3K/Akt/mTOR (1)
- POEM (1)
- Primary hyperparathyroidism (pHPT) (1)
- RET6 (1)
- RNAPOL1 (1)
- Radiochemotherapy (1)
- Roux-en-Y gastric bypass (1)
- SARS-CoV-2 (1)
- SSI (1)
- Surgery (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T cell receptors (1)
- T cells (1)
- TCR signaling cascade (1)
- TME (1)
- Time interval (1)
- V. saphena magna (1)
- Y-gastric bypass (1)
- ZfKD (1)
- [11C]-Choline PET/CT (1)
- [11C]-Methionine (1)
- [99mTc]-Sestamibi scan (1)
- abdominal surgery (1)
- achalasia (1)
- adjuvant (1)
- adrenal cancer (1)
- adrenal surgery (1)
- adrenocortical carcinoma (1)
- alternative splicing (1)
- anastomosis (1)
- anastomotic leak (1)
- anastomotic leakage (1)
- anorectal abscess (1)
- antibiotic prescribing quality (1)
- antibiotic prescription behavior (1)
- antibiotic resistance (1)
- anticoagulation (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- atrial fibrillation (1)
- autophagy (1)
- bariatric surgery (1)
- benzoquinone (1)
- biliopancreatic diversion (1)
- bladder (1)
- body weight (1)
- brain metastases (1)
- bridging (1)
- caco-2 cells (1)
- cancer (1)
- cancer cells (1)
- cancer diagnosis (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- capture (1)
- carcinomas (1)
- case report (1)
- catheterization (1)
- catheters (1)
- cell cycle and cell division (1)
- cerebral metastases (1)
- chemistry (1)
- cholestasis (1)
- colon (1)
- colon cancer (1)
- colon resection (1)
- colorectal carcinoma (1)
- complications (1)
- conventional laparoscopic appendectomy (1)
- cost-effectiveness (1)
- cotransporter SGLT1 (1)
- curative resection (1)
- cytostatic (1)
- cytotoxicity (1)
- definition (1)
- desmosome (1)
- diagnosis (1)
- diagnostics (1)
- discharge definition (1)
- drug-eluting beads (1)
- duodenal jejunal bypass (1)
- elective surgery (1)
- endoscopic (1)
- enteric glial cells (1)
- enteric nervous system (1)
- enteroids (1)
- ephitelial cells (1)
- epidemiology (1)
- epidural block (1)
- epithelium (1)
- esophageal perforation (1)
- fish bone (1)
- fistulizing Crohn’s Disease (1)
- flow cytometry (1)
- focused surgical approach (1)
- food intake (1)
- foreign body ingestion (1)
- gastrointestinal infections (1)
- gastrointestinal perforation (1)
- gene regulation (1)
- geriatric (1)
- germline mutation (1)
- glucagon like peptide-1 (1)
- glucose metabolism (1)
- gut hormones (1)
- hepatic resection (1)
- hepatocellular carcinoma (1)
- imaging (1)
- inflammatory cell model (1)
- inguinal lymph node dissection (1)
- intercellular junctions (1)
- intestinal barrier (1)
- intestinal glucose (1)
- intestinal organoids (1)
- intraabdominal abscess (1)
- intragastric balloon (1)
- laparoscopic right colectomy (1)
- left hemicolectomy (1)
- liver resection (1)
- low-grade mucinous neoplasm (1)
- low-molecular heparin (1)
- low-risk intra-abdominal infections (1)
- lung resection (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- malignant melanoma (1)
- mastocytosis (1)
- measles virus (1)
- metachronous (1)
- multimodal (1)
- negative pressure wound therapy (1)
- neoadjuvant (1)
- neurotrophic factors (1)
- obesity (1)
- octogenarians (1)
- octogenerians (1)
- older adult (1)
- open wound treatment (1)
- operative (1)
- organoid (1)
- oxaliplatin (1)
- pancreatectomy (1)
- pancreatic adenocarcinoma (PDAC) (1)
- pancreatic head cancer (1)
- parathyroid adenoma (1)
- patient-derived organoid (PDOs) (1)
- patient-derived tumor organoid (PDTO) (1)
- penetrating ileitis (1)
- perianal fistulas (1)
- perioperative antibiotic prophylaxis (1)
- perioperative chemotherapy (1)
- peroral endoscopic myotomy (1)
- platelet dysfunction (1)
- post-operative antibiotic treatment (1)
- postoperative bleeding (1)
- postoperative inflammation (1)
- preoperative localization (1)
- primary hyperparathyroidism (1)
- prognosis (1)
- prospective studies (1)
- protein expression (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- reactive oxygen species (1)
- rectum (1)
- recurrence survival (1)
- regional recurrence (1)
- repeat surgery (1)
- retrospective study (1)
- reverse transcriptase-polymerase chain reaction (1)
- review (1)
- ribosome (1)
- risk factor (1)
- risk factors (1)
- robotic surgery (1)
- screening (1)
- secondary skin closure (1)
- seminoma (1)
- single-port appendectomy (1)
- sleeve gastrectomy (1)
- small interferring RNA (1)
- super-obesity (1)
- superior (1)
- surgical (1)
- surgical and invasive medical procedures (1)
- surgical care (1)
- surgical intra-abdominal infections (1)
- surgical management (1)
- surgical oncology (1)
- surgical outcome (1)
- surgical procedures (1)
- surgical resection (1)
- surgical site infection (1)
- surgical site infections (1)
- survival (1)
- survival analysis (1)
- systematic review (1)
- terminal ileitis (1)
- thromboembolism (1)
- thyroid gland (1)
- thyroiditis (1)
- tight junction (1)
- transarterial chemoembolization (1)
- treatment (1)
- tumor disease (1)
- urinary tract infections (1)
- vascular type (1)
- vitamin D (1)
- wound infection (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (59)
- Theodor-Boveri-Institut für Biowissenschaften (21)
- Comprehensive Cancer Center Mainfranken (13)
- Medizinische Klinik und Poliklinik II (10)
- Medizinische Klinik und Poliklinik I (5)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (4)
- Pathologisches Institut (4)
- Institut für Anatomie und Zellbiologie (3)
- Kinderklinik und Poliklinik (3)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 101042738 (1)
Background
Fermented wheat germ extract (FWGE) sold under the trade name Avemar exhibits anticancer activity in vitro and in vivo. Its mechanisms of action are divided into antiproliferative and antimetabolic effects. Its influcence on cancer cell metabolism needs further investigation. One objective of this study, therefore, was to further elucidate the antimetabolic action of FWGE. The anticancer compound 2,6-dimethoxy-1,4-benzoquinone (DMBQ) is the major bioactive compound in FWGE and is probably responsible for its anticancer activity. The second objective of this study was to compare the antiproliferative properties in vitro of FWGE and the DMBQ compound.
Methods
The IC\(_{50}\) values of FWGE were determined for nine human cancer cell lines after 24 h of culture. The DMBQ compound was used at a concentration of 24 μmol/l, which is equal to the molar concentration of DMBQ in FWGE. Cell viability, cell cycle, cellular redox state, glucose consumption, lactic acid production, cellular ATP levels, and the NADH/NAD\(^+\) ratio were measured.
Results
The mean IC\(_{50}\) value of FWGE for the nine human cancer cell lines tested was 10 mg/ml. Both FWGE (10 mg/ml) and the DMBQ compound (24 μmol/l) induced massive cell damage within 24 h after starting treatment, with changes in the cellular redox state secondary to formation of intracellular reactive oxygen species. Unlike the DMBQ compound, which was only cytotoxic, FWGE exhibited cytostatic and growth delay effects in addition to cytotoxicity. Both cytostatic and growth delay effects were linked to impaired glucose utilization which influenced the cell cycle, cellular ATP levels, and the NADH/NAD\(^+\) ratio. The growth delay effect in response to FWGE treatment led to induction of autophagy.
Conclusions
FWGE and the DMBQ compound both induced oxidative stress-promoted cytotoxicity. In addition, FWGE exhibited cytostatic and growth delay effects associated with impaired glucose utilization which led to autophagy, a possible previously unknown mechanism behind the influence of FWGE on cancer cell metabolism.